日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immunity in neuromodulation: probing neural and immune pathways in brain disorders

神经调控中的免疫:探索脑部疾病中的神经和免疫通路

Hours, C; Vayssière, Pia; Gressens, P; Laforge, M

Unveiling the dual reactivity of nanoscaled PuO(2) sonicated in oxygenated aqueous solutions

揭示纳米级PuO(2)在含氧水溶液中超声处理的双重反应活性

Margate, Julien; Virot, Matthieu; Dumas, Thomas; Bayle, Simon; Menut, Denis; Bonato, Laura; Broussard, Emilie; Molière, Fanny; Hours, Charles; Venault, Laurent; Nikitenko, Sergey I

A Closer Look at Dystonia with the Glycosylation

深入了解糖基化与肌张力障碍的关系

Camille, Hours; Pierre, Gressens

Molecular and Cellular Insights: A Focus on Glycans and the HNK1 Epitope in Autism Spectrum Disorder

分子和细胞层面的见解:聚焦自闭症谱系障碍中的聚糖和HNK1表位

Hours, Camille M; Gil, Sophie; Gressens, Pierre

Life expectancy tables for dogs and cats derived from clinical data

根据临床数据得出的犬猫预期寿命表

Montoya, Mathieu; Morrison, Jo Ann; Arrignon, Florent; Spofford, Nate; Charles, Hélène; Hours, Marie-Anne; Biourge, Vincent

Diagnostic radiological examinations and risk of intracranial tumours in adults-findings from the Interphone Study

诊断性放射学检查与成人颅内肿瘤风险——来自Interphone研究的发现

Auvinen, Anssi; Cardis, Elisabeth; Blettner, Maria; Moissonnier, Monika; Sadetzki, Siegal; Giles, Graham; Johansen, Christoffer; Swerdlow, Anthony; Cook, Angus; Fleming, Sarah; Berg-Beckhoff, Gabriele; Iavarone, Ivano; Parent, Marie-Elise; Woodward, Alistair; Tynes, Tore; McBride, Mary; Krewski, Dan; Feychting, Maria; Takebayashi, Toru; Armstrong, Bruce; Hours, Martine; Siemiatycki, Jack; Lagorio, Susanna; Larsen, Signe Benzon; Schoemaker, Minouk; Klaeboe, Lars; Lönn, Stefan; Schüz, Joachim

Erenumab versus topiramate for the prevention of migraine - a randomised, double-blind, active-controlled phase 4 trial

依瑞奈单抗与托吡酯预防偏头痛的比较——一项随机、双盲、阳性对照的4期临床试验

Reuter, Uwe; Ehrlich, Marc; Gendolla, Astrid; Heinze, Axel; Klatt, Jan; Wen, Shihua; Hours-Zesiger, Peggy; Nickisch, Jacqueline; Sieder, Christian; Hentschke, Christian; Maier-Peuschel, Monika

Long-term Efficacy and Safety of Erenumab: Results From 64 Weeks of the LIBERTY Study

Erenumab的长期疗效和安全性:LIBERTY研究64周的结果

Goadsby, Peter J; Reuter, Uwe; Lanteri-Minet, Michel; Paiva da Silva Lima, Gabriel; Hours-Zesiger, Peggy; Fernandes, Chrystel; Wen, Shihua; Tenenbaum, Nadia; Kataria, Aditi; Ferrari, Michel D; Klatt, Jan

Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2-4 preventives were not useful: results from the LIBERTY study

依瑞奈单抗对 2-4 种预防性药物无效的发作性偏头痛患者功能结局的影响:LIBERTY 研究的结果

Lanteri-Minet, Michel; Goadsby, Peter J; Reuter, Uwe; Wen, Shihua; Hours-Zesiger, Peggy; Ferrari, Michel D; Klatt, Jan

Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study

一项针对亚洲、中东和拉丁美洲患者预防发作性偏头痛的erenumab随机对照试验:EMPOwER研究

Wang, Shuu-Jiun; Roxas, Artemio A Jr; Saravia, Bibiana; Kim, Byung-Kun; Chowdhury, Debashish; Riachi, Naji; Tai, Mei-Ling Sharon; Tanprawate, Surat; Ngoc, Tai Tran; Zhao, Yi Jing; Mikol, Daniel D; Pandhi, Shaloo; Wen, Shihua; Mondal, Subhayan; Tenenbaum, Nadia; Hours-Zesiger, Peggy